Researcher Profile

Keywords Cloud

KRIBB Co-Working

Results 1-20 of 97 (Search time: 0.007 seconds).

No. Year Title Type
97 2022

2022Research Project

국가 재난형 바이러스 예방·치료 원천기술 개발 = Development of fundamental technology for prevention and therapy of viral disease연구책임자 : 부하령 / 사업기간 : 2022.01.01 ~ 2022.12.31
Research Project
96 2022

2022Research Project

번역개시인자 eIF3A 매개 유전자 선택번역과 암발생에 관한 연구 및 eIF3A 적중 PROTAC 단백질분해 기술 기반 구축 = Oncogenic Translation triggered by Aberrant Expression of Translation Initiation Factor eIF3A and Development of the‘PROTAC’t연구책임자 : 조은위 / 사업기간 : 2022.03.01 ~ 2023.02.28
Research Project
95 2021

2021Patent

엑소좀 단백질 EIF3A 특이반응 오토항체검출용 항원 조성물 및 이를 이용한 간암진단법CN201680052859.4 (2018.03.12) / ZL201680052859.4 (2021.11.02)고정헌; 황해민; 허창규; 조은위
Patent
94 2021

2021Patent

유전성 강직성 하반신마비 질환 원인 신규 변이체를 동정하는 방법 및 유전 강직성 하반신마비 진단용 칩KR10-2018-0084998 (2018.07.20) / 10-2257221 (2021.05.21)조은위김남순이재란정초록정경숙김대수이다용이정주; 김완태; 이용재
Patent
93 2021

2021Patent

뚜렛증후군의 원인 유전자를 동정하는 방법KR10-2019-0070779 (2019.06.14) / 10-2250063 (2021.05.03)김남순정경숙김대수조은위; 임원희; 이정주
Patent
92 2021

2021Article

Targeting therapy-resistant lung cancer stem cells via disruption of the AKT/TSPYL5/PTEN positive-feedback loopCommunications Biology, vol. 4, pp. 778-778I G Kim; J H Lee; S Y Kim; Chang-Kyu Heo; R K Kim; Eun Wie Cho
Article
91 2021

2021Research Project

번역개시인자 eIF3A 매개 유전자 선택번역과 암발생에 관한 연구 및 eIF3A 적중 PROTAC 단백질분해 기술 기반 구축 = Oncogenic Translation triggered by Aberrant Expression of Translation Initiation Factor eIF3A and Development of the‘PROTAC’t연구책임자 : 조은위 / 사업기간 : 2021.03.01 ~ 2022.02.28
Research Project
90 2021

2021Research Project

국가 재난형 바이러스 예방·치료 원천기술 개발 = Development of fundamental technology for prevention and therapy of viral disease연구책임자 : 부하령 / 사업기간 : 2021.01.01 ~ 2021.12.31
Research Project
89 2020

2020Patent

엑소좀 단백질 EIF3A 특이반응 오토항체검출용 항원 조성물 및 이를 이용한 간암진단법US15/743,471 (2018.01.10) / 10,809,263 (2020.10.20)고정헌; 황해민; 허창규; 조은위
Patent
88 2020

2020Article

Cyclic peptide mimotopes for the detection of serum anti-ATIC autoantibody biomarker in hepato-cellular carcinomaInternational Journal of Molecular Sciences, vol. 21, no. 24, pp. 9718-9718Chang Kyu Heo; Hai Min Hwang; Won-Hee Lim; H J Lee; J S Yoo; K J Lim; Eun Wie Cho
Article
87 2020

2020Article

HSPA1L enhances cancer stem cell-like properties by activating IGF1Rβ and regulating β-catenin transcriptionInternational Journal of Molecular Sciences, vol. 21, no. 18, pp. 6957-6957S I Choi; J H Lee; R K Kim; U Jung; Y J Kahm; Eun Wie Cho; I G Kim
Article
86 2020

2020Research Project

희귀 신경계질환 정밀·맞춤의학 원천 기술 개발 = Development of Genome-based Platform Technologies for Precision Medicine of Rare Neurological Diseases연구책임자 : 김남순 / 사업기간 : 2020.01.01 ~ 2020.12.31
Research Project
85 2020

2020Research Project

국가 재난형 바이러스 예방·치료 원천기술 개발 = Development of fundamental technology for prevention and therapy of viral disease연구책임자 : 부하령 / 사업기간 : 2020.01.01 ~ 2020.12.31
Research Project
84 2020

2020Research Project

번역개시인자 eIF3A 매개 유전자 선택번역과 암발생에 관한 연구 및 eIF3A 적중 PROTAC 단백질분해 기술 기반 구축 = Oncogenic Translation triggered by Aberrant Expression of Translation Initiation Factor eIF3A and Development of the‘PROTAC’t연구책임자 : 조은위 / 사업기간 : 2020.03.01 ~ 2021.02.28
Research Project
83 2019

2019Article

Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinomaScientific Reports, vol. 9, pp. 11059-11059Chang Kyu Heo; Hai Min Hwang; H J Lee; Sang-Seob Kwak; J S Yoo; Dae Yeul Yu; K J Lim; S Lee; Eun Wie Cho
Article
82 2019

2019Research Project

희귀 신경계질환 정밀·맞춤의학 원천 기술 개발 = Development of Genome-based Platform Technologies for Precision Medicine of Rare Neurological Diseases연구책임자 : 김남순 / 사업기간 : 2019.01.01 ~ 2019.12.31
Research Project
81 2018

2018Report

희귀난치성 신경계질환 정밀의료 기술개발 = Development of Genome-based Platform Technologies for Precision Medicine of Rare Neurological Diseases연구책임자 : 김남순 / 주관부처 : 미래창조과학부김남순김대수조은위정경숙이재란이다용; 김완태; 이정주
Report
80 2018

2018Patent

디지털 PCR을 이용한 유전성 강직성 대마비(Hereditary spastic paraplegia, HSP) 관련 유전자 SPG4의 거대결손 검증법KR10-2017-0118643 (2017.09.15) / 10-1889072 (2018.08.09)조은위김남순이재란; 황해민; 김대수조현수정경숙정초록
Patent
79 2018

2018Article

Hypoxia-inducible transgelin 2 selects epithelial-to-mesenchymal transition and γ-radiation-resistant subtypes by focal adhesion kinase-associated insulin-like growth factor 1 receptor activation in non-small-cell lung cancer cellsCancer Science, vol. 109, no. 11, pp. 3519-3531I G Kim; J H Lee; S Y Kim; Hai Min Hwang; T R Kim; Eun Wie Cho
Article
78 2018

2018Article

Tescalcin/c-Src/IGF1Rβ-mediated STAT3 activation enhances cancer stemness and radioresistant properties through ALDH1Scientific Reports, vol. 8, pp. 10711-10711J H Lee; S I Choi; R K Kim; Eun Wie Cho; I G Kim
Article
1 2 3 4 5